HPV study for women at higher risk in Scotland
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study looks at ways to improve cervical cancer prevention for women in Scotland who face extra challenges, such as addiction, homelessness, prison, or sex work. It includes a vaccination and screening part, plus an interview to hear your views.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a cervix (not removed by surgery).
- You are between 25 and 45 years old.
- You have been affected by drug or alcohol problems, prison stay, homelessness, or sex work.
- You are able to make your own decision to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.
This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.
This observational study looks at HPV infections and women's views about the HPV vaccine in Slovenia. It aims to understand the characteristics of HPV infections and attitudes toward vaccination after the vaccine became available.
This study looks at how well the HPV vaccine works in women who have already been exposed to the virus through sexual activity. It aims to understand the immune response and potentially improve protection against HPV-related cancers.
This trial aims to develop a vaccine that trains your immune system to fight HPV, the virus that causes cervical cancer. By studying your blood, researchers hope to find better ways to prevent the cancer from coming back.
This trial tests a way to give HPV vaccines along with routine childhood immunizations in Ghana. It aims to protect against HPV, a virus that can cause cervical cancer, by making it easier to get the vaccine.
Hear when a new Human Papilloma Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.